Tạp chí Tim mạch học Việt Nam

Article detail

Article detail description

Home
NGHIÊN CỨU LÂM SÀNG Issue: Số 106 năm 2023 BỆNH ĐỘNG MẠCH NGOẠI VI

Dyslipidemia patterns in patients with peripheral artery disease

Kim Ngọc Thanh: Trường Đại học Y Hà Nội; Lê Hùng Tiến: Trường Đại học Y Hà Nội; Nguyễn Tuấn Hải: Trường Đại học Y Hà Nội; Trương Thanh Hương: Trường Đại học Y Hà Nội;
Published: August 1, 2023
Views: 136

Abstract

The objective of this study was to characterize blood lipids in individuals with lower extremity arterial disease (LEAD). The cross-sectional descriptive study included individuals with LEAD who were treated at the Vietnam National Heart Institute, Bach Mai Hospital. The results of the study showed that among 229 individuals with LEAD, 78.6% were men, and 63.3% had a Rutherford classification of grade IV-VI. The rate of patients with plasma levels of total cholesterol >5.2mmol/L, LDL-C >3.6 mmol/L, HDL-C <1.0 mmol/L, and triglyceride >1.7 mmol/L was 25.8%, 18.8%, 50.2%, and 42.8%, respectively. However, only 5.2% of patients were used high-intensity statins such as rosuvastatin 20 mg. In summary, the study found that dyslipidemia was common in patients with LEAD.

References

1.
Song, P., et al., Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis. Lancet Glob Health, 2019. 7(8): p. e1020-e1030.
2.
Aboyans, V., et al., 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J, 2018. 39(9): p. 763-816.
3.
Nguyễn Trường Sơn, et al., Hướng dẫn chẩn đoán và điều trị bệnh động mạch chi dưới. Tạp chí Tim mạch học Việt Nam, 2022(102): p. 5-19.
4.
Trần Xuân Thủy và Đinh Thị Thu Hương, Một số yếu tố liên quan tới chỉ số huyết áp tâm thu cổ chân- cánh tay (ABI) ở bệnh nhân bị bệnh động mạch chi dưới. Tạp chí y học Việt Nam, 2021. 500: p. 116-119.
5.
Yi, C., et al., Association between lipoprotein(a) and peripheral arterial disease in coronary artery bypass grafting patients. Clin Cardiol, 2023. 46(5): p. 512-520.
6.
Verwer, M.C., et al., High lipoprotein(a) is associated with major adverse limb events after femoral artery endarterectomy. Atherosclerosis, 2022. 349: p. 196-203.
7.
West, R., Tobacco smoking: Health impact, prevalence, correlates and interventions. Psychol Health, 2017. 32(8): p. 1018-1036.
8.
Aday, A.W. and B.M. Everett, Dyslipidemia Profiles in Patients with Peripheral Artery Disease. Curr Cardiol Rep, 2019. 21(6): p. 42.
9.
Murabito, J.M., et al., Intermittent claudication. A risk profile from The Framingham Heart Study. Circulation, 1997. 96(1): p. 44-9.
10.
Ness, J., W.S. Aronow, and C. Ahn, Risk factors for symptomatic peripheral arterial disease in older persons in an academic hospital-based geriatrics practice. J Am Geriatr Soc, 2000. 48(3): p. 312-4.
11.
Murabito, J.M., et al., Prevalence and clinical correlates of peripheral arterial disease in the Framingham Offspring Study. Am Heart J, 2002. 143(6): p. 961-5.
12.
Mach, F., et al., 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS). European Heart Journal, 2019. 41(1): p. 111-188.
13.
Visseren, F.L.J., et al., 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: Developed by the Task Force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies With the special contribution of the European Association of Preventive Cardiology (EAPC). European Heart Journal, 2021. 42(34): p. 3227-3337.
14.
Olov Wikluynd, et al., The Clinician’s Handbook: Dyslipidaemia and Atherosclerosis Prevention, Diagnosis and Treatment. 2023: European Atherosclerosis Society.
15.
Hirsch, A.T. and A.M. Gotto, Jr., Undertreatment of dyslipidemia in peripheral arterial disease and other high-risk populations: an opportunity for cardiovascular disease reduction. Vasc Med, 2002. 7(4): p. 323-31.
16.
Thalmann, I., et al., Population-wide cohort study of statin use for the secondary cardiovascular disease prevention in Scotland in 2009-2017. Heart, 2023. 109(5): p. 388-395.
17.
Aboyans, V. and L. Chastaingt, What LEADs to the under-treatment of patients with lower-extremity artery disease? European Journal of Preventive Cardiology, 2023.

Files

Article Views136
Document Views1
Downloads0
Section NGHIÊN CỨU LÂM SÀNG
Category BỆNH ĐỘNG MẠCH NGOẠI VI